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CHAPTER 1: INTRODUCTION 
HDAC inhibitors 
 The acetylation and deacetylation of histones form an important and highly controlled 
regulatory mechanism in a cell’s gene expression. Histone acetyltransferase (HAT) enzymes 
catalyze the addition of acetyl groups to the lysine residues of histones, negating their positive 
charge and permitting the DNA wound around them to loosen into a more relaxed and 
transcriptionally active state.  Conversely, histone deacetylases (HDACs) catalyze the removal of 
acetyl groups from lysine residues and promote formation of a more compact chromatin. 
HDACs are capable of deacetylating a variety of other non-histone proteins as well; one review 
cites more than 50 proteins that have been identified (1). It has been suggested the ability of 
HDACs to deacetylate non-histone proteins gives them a variety of other functions and they 
should more accurately be called lysine deacetylases (1,2). Of the 18 known human HDACs and 
the four classes they are identified by, class I and class II HDACs contain a zinc-dependent active 
site that is competitively bound to by histone deacetylase inhibitors (HDACis). HDACis acting on 
zinc-dependent HDACs fall into four categories in order of decreasing potency: Hydroxamic 
acids (e.g. trichostatin A (TSA)), cyclic tetrapeptides, benzamides, and short chain carboxylic 
acids (e.g. valproic acid (VPA) and phenylbutyric acid (PBA)) (2,3) (Figure 1).  
Since it was observed that HDAC activity is increased in cancer cells, HDAC inhibitors 
were first investigated as anti-cancer agents. HDAC inhibitors can induce the cell cycle regulator 
p21 in cancer cells and induce cell cycle arrest, thus inhibiting their proliferation (2). Two HDAC 
inhibitors, Vorinostat and Romidepsin, have been approved by the FDA for the 
treatment
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of cutaneous T-cell lymphoma.  
HDAC inhibitors also possess anti-inflammatory properties when used at significantly 
lower concentrations than those used in cancer treatment. In many autoimmune and 
inflammatory diseases such as rheumatoid arthritis (RA) and atherosclerosis there exists an 
improper activation of macrophages because of an overexpression of cytokines such as TNF-α, 
IL-6, IL-1β. The efficacy of anti-cytokine antibodies in reducing inflammation in these diseases 
demonstrates the central role cytokines play in their pathology (4,5). Whereas anti-cytokine 
antibodies must be delivered parenterally, HDAC inhibitors are orally active at low 
concentrations (4). Several studies have demonstrated a significant reduction in cytokine levels 
in vitro and in animal models when exposed to HDAC inhibitors (4). In one study, 
phenylbutyrate (2mM and 5mM) suppressed IL-6 and TNF-α production in human macrophages 
in vitro when stimulated with lipopolysaccharides (LPS) (5). Intact synovial biopsy explants from 
patients with RA stimulated by TNF-α in the presence of phenylbutyrate (1mM, 2mM and 5mM) 
displayed reduced production of IL-6, IL-8, IL-10, and a host of chemokines. No clear correlation 
 
Figure 1: A selection of HDAC inhibitors. 
Trichostatin A (TSA) 
Phenylbutyric acid 
Valproic acid (VPA) 
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was found between macrophage histone acetylation and cytokine reduction. Considering the 
unintuitive observation that patients with RA and chronic obstructive pulmonary disease 
(COPD) display reduced HDAC activity at the disease site, it is likely that the targeting of non-
histone proteins by HDACis plays a larger role in their anti-inflammatory activity.  
Induced Pluripotent Stem Cells 
 In 2006, the team of Yamanaka et al. energized the field of stem cell research by 
successfully generating the first induced pluripotent stem cells (iPSCs). By forcing expression of 
four transcription factors (Oct4, Klf4, Sox2, and c-Myc) via retroviral vector in mouse embryonic 
fibroblasts (MEFs), a fully differentiated somatic cell type could be dedifferentiated into an 
embryonic stem (ES) cell-like state (6). The expression of these four genes is noted in embryonic 
stem cells for their ability to sustain a pluripotent state. The extent of equivalence between 
iPSCs and ESCs is under continued investigation, but there exist many commonalities including 
morphology, capability for unlimited self-renewal, expression of cell surface markers, 
demethylation of pluripotency gene promoters, and similarity in global DNA methylation. Like 
ESCs, iPSCs are capable of differentiating into multiple types of tissue. A common verification of 
pluripotency is to inject iPSCs in immunodeficient mice and observe the formation of teratomas 
containing tissue from all three germ layers. iPSCs were successfully generated from human 
fibroblasts using the same four transcription factors soon after (7). 
 The process for generation of iPSCs carries with it a number of drawbacks that have 
limited its potential for wide-scale adoption. The four-factor retroviral approach by Yamanaka 
et al. can only reprogram somatic cells at a very low rate (<1%) and the indiscriminate approach 
retroviruses take in inserting their genome poses a risk of mutation to the cell. Some 
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reprogramming factors (c-Myc in particular) are oncogenes and thus tumor formation is a major 
concern to be addressed. Alternate vectors have been investigated in an attempt to ameliorate 
these drawbacks: Adenoviruses (8), plasmids (9), and recombinant proteins (10) have all 
demonstrated success in producing iPSCs. However, each of these alternatives reduces the 
already low efficiency of reprogramming. 
 A promising route to the generation of iPSCs is the addition of small compounds to 
mimic and substitute for transcription factors or catalyze the process.  In 2008, Melton et al. 
studied the effect of several small molecule compounds including the HDAC inhibitors 
suberoylanilide hydroxamic acid (SAHA), trichostatin A (TSA) and valproic acid (VPA) on four-
factor transfection of MEFs (11). After one week of treatment, VPA (2 mM) appeared much 
more potent than any other compound and increased the percent of Oct4-expressing cells by 
>100-fold versus a non-treated four-factor control. When the expression of oncogene c-Myc 
was no longer forced, VPA increased efficiency by 50-fold versus a non-treated three-factor 
control. Importantly, three-factor transfection with VPA was more efficient than all four factors 
without VPA. VPA treatment did not affect the resemblance of iPSCs to ES cells in any way 
measured. Mouse embryos injected with VPA-treated iPSCs developed into healthy adult 
chimeras containing iPSC-differentiated cells from all three germ layers. These findings have 
generated interest in the transcription factor/small molecule compound combination approach 
to iPSCs.  
Layer-by-layer thin films 
 Layer-by-layer deposition describes the process of assembling oppositely charged 
polyelectrolytes that are attracted by electrostatic forces on a surface. The deposition process 
5 
 
 
can be repeated to form multilayer nano-to-micro scale thin films. Polyelectrolytes for film 
formation can include both synthetic charged polymers and natural charged 
biomacromolecules such as DNA and proteins. Assembling a layer-by-layer film with 
biomacromolecules presents many advantages that make it an attractive approach to drug 
delivery and cell transfection (12). Because the layers are modular and contain discrete 
concentrations of biomacromolecules, the timing and order of delivery can be precisely 
controlled. More than one biomacromolecule can be delivered from the same film. The 
methods of film deposition permit their use on complex shapes at small scale, including 
particles and scaffolds. Layers can be fabricated from anionic plasmid DNA and cationic 
degradable polymers that form polyplexes, permitting the condensation and delivery of DNA 
into a cell.  
Hypothesis and specific aims 
HDAC inhibitors are known to have anti-inflammatory properties. HDAC inhibitors are 
used in combination with Oct4 to generate induced pluripotent stem cells. I hypothesize that 
polyesters based on simple aliphatic HDAC inhibitors like valproic acid (VPA) and phenylbutyric 
acid (PBA) can serve as alternatives to existing polyester biomaterials with improved anti-
inflammatory properties and as scaffolds for generation of iPSCs when used in combination 
with layer-by-layer thin films delivering reprogramming transcription factors.  
Specific aims of the study are as follows: 
• Synthesize vinyl ester of valproic acid (VEVA) and vinyl ester of phenylbutyric acid 
(VEPA) 
• Synthesize and characterize poly(VEVA) and poly(VEPA) 
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• Characterize hydrolysis of poly(VEVA) and poly(VEPA) and release of VPA and PBA 
• Determine HDAC inhibition of poly(VEVA) and poly(VEPA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 2: SYNTHESIS AND CHARACTERIZATION OF HDAC
Free radical vinyl polymerization
A common and versatile method of synthesizing polymers is the chain growth of vinyl 
monomers by addition of free radical initiators. 
vinyl polymerization include poly(vinyl acetate), poly(methyl methacrylate), polyethylene, 
poly(vinyl chloride) and polystyrene. 
peroxide (BPO) and azobisisobutyronitrile (AIBN) (Figure 2). 
a functional group that can be decomposed
containing free radicals (Figure 3). 
monomer is introduced to an initiator fragment, the double bond is attacked by free radicals 
and opens up to accept a new electron pair
generated that can react with a new
sequence. Eventually, the process is terminated by 
(coupling), or the abstraction of a hydrogen atom from one chain to another to form a terminal 
double bond (disproportionation). 
polymer chain. Abstracting a hydrogen atom from solvent ter
necessitating careful selection of solvent type
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Many such polymers produced by free radical 
Two common initiators used in this process are benzoyl 
These symmetrical molecules have 
 by heat, separating them into fragment p
When the carbon double bond of a vinyl group
 with the initiator fragment.  An unpaired electron is 
 vinyl group and add to the growing polymer cha
recombination of two growing chain ends 
A variety of chain transfer agents act to stunt the growth of a 
minates chain propagation, 
. Chain transfer to initiator terminates a
Figure 2: Common free radical initiators. 
 
airs 
 of a 
in in 
 chain 
 
  
while propagating a new one. If a hydr
continues propagating but the formed polymer becomes
Monomer synthesis 
 In order to perform free radical vinyl polymer
the monomer. Vinyl esters are a commonly used intermediate 
methods for their production exist in the literature and in industry. A common method of vinyl 
ester synthesis is the transvinylation of carboxylic acids with vinyl acetate catalyzed by 
transition metal complexes. Mercuric acetate is an efficient catalyst
mercury makes it undesirable. 
delivers poor yield (15). Some ruthenium compounds are suitable catalysts, but they dema
elevated reaction temperatures (16)
Figure 3: Thermal decomposition of AIBN and benzoyl peroxide.
8 
ogen atom is abstracted from another chain, 
 branched.  
ization, a vinyl group has
in organic chemistry 
 (13), but the toxicity of 
Palladium is a well-established industrial catalyst (
. Nakagawa et al. demonstrated the effectiveness of an 
 
one chain 
 to be present in 
and several 
14) but 
nd 
  
iridium complex bis(1,5-cyclooctadiene)diiridium(I) dichloride
vinyl acetate with several carboxylic 
with 10 eq vinyl acetate in the presence of 1 mol
(NaOAc) (Figure 4) in toluene at 100 
without NaOAc lowered the % conversion.
80% conversion. An excess of vinyl acetate is used in the rea
equilibrium toward the product 
 Figure 5 describes the scheme
Figure 4: Catalysts bis(1,5-cyclooctadiene)diiridium(I) dichloride
Figure 5: Reaction scheme for the synthesis of VEPA and VEVA from their carboxylic acid precursors.
9 
 ([Ir(cod)Cl]2) in the reaction of 
acids (17). In a typical reaction, carboxylic acid was reacted 
% [Ir(cod)Cl]2 and 3 mol% sodium acetate 
°C for 15 hr under argon atmosphere. Running the reaction 
 Reacting cinnamic acid with vinyl acetate resulted in 
ction in order to push the
side.  
 for the reaction of phenylbutyric acid and valproic acid 
 ([Ir(cod)Cl]2) and sodium acetate (NaOAc).
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with vinyl acetate to form corresponding vinyl esters. Table 1 lists the conditions of each 
reaction performed and their associated % yield. Phenylbutyric acid or valproic acid was 
reacted with 10 eq (later 20 eq) of vinyl acetate in the presence of 1 mol% [Ir(cod)Cl]2 and 3 
mol% NaOAc refluxed at 100 °C in toluene for 15 hr under nitrogen. Consumption of the 
carboxylic acid at the end of 15 hr was verified by thin layer chromatography (TLC). TLC was run 
with 4:1 (VEPA Rf = 0.78) or 10:1 (VEPA Rf = 0.49) hexanes:ethyl acetate and visualized with 
either Seebach’s stain (VEPA) or iodine vapor (VEVA). Product was concentrated on rotary 
evaporator and vacuum filtered with 5 μm filter paper. Purification was performed by column 
Carboxylic acid Vinyl acetate Solvent Reaction time % yield 
1 mmol PBA 10 eq 3 mL toluene 15 hr 47 
10 mmol PBA 20 eq 30 mL toluene 15 hr 86 
7.4 mmol PBA 20 eq 22 mL toluene 20 hr 88 
15 mmol PBA 20 eq 45 mL toluene 16 hr 97 
15 mmol PBA 20 eq 45 mL toluene 16 hr 93 
10 mmol VPA 20 eq 30 mL toluene 15 hr 20 
10 mmol VPA 20 eq 30 mL toluene 15 hr 71 
19.7 mmol VPA 20 eq 59 mL toluene 15 hr 73 
19.7 mmol VPA 20 eq 59 mL toluene 15 hr 69 
Table 1: Reaction conditions for the synthesis of VEPA and VEVA. 
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Figure 6: Proton NMR spectra of VEPA in chloroform. 
Figure 7: Proton NMR spectra of VEVA in chloroform. 
A 
A 
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A 
A 
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C D 
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F 
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chromatography using 20:1 hexanes:ethyl 
VEPA; initial concentration of VEVA on rota
temperature and run twice in order to minimize evaporation of 
with the volatility of VEVA led to 
to the reactants improved the % yield. 
oils and are soluble in methanol, ace
 Identity and purity of VEPA and VEVA monomers were
chloroform (Figure 6, Figure 7). The only example of VEPA syn
includes NMR data that were successfully
facilitated with published NMR spectra of VPA. 
distinct indicating a successful purification and 
Poly(vinyl butyrate) as test case 
 In order to optimize and
and VEVA monomers, a commercially available vinyl ester of similar structure was examined. 
Vinyl butyrate was polymerized by
common polymer manufacturing techniques
Figure 8: Free radical polymerization of vinyl butyrate.
12 
acetate. VEVA was markedly more volatile than 
ry evaporator was thus performed
the monomer. 
low % yield initially. Adding additional excess of vinyl acetate 
VEPA and VEVA appear as faintly yellowish 
tone, hexanes and ethyl acetate but insoluble in water.
 verified by 
thesis found in the literature (18)
 replicated here. Identification of VEV
NMR peaks of both monomers were clean and 
suitability for use in polymerizat
 practice polymerization methods prior to polymerizing VEPA 
 AIBN to form poly(vinyl butyrate) (Figure 8). 
 to choose from:  
 
 at lower bath 
Unfamiliarity 
transparent 
  
proton NMR in 
 
A by NMR was 
ion studies. 
 There are a few 
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• Bulk polymerization, a reaction of monomer and initiator only 
• Solution polymerization, a reaction of monomer and initiator dissolved in a solvent 
• Suspension polymerization, a reaction consisting of a liquid phase and a mechanically 
agitated oil phase of suspended monomer droplets 
Solution polymerization was chosen as the synthetic method here because the reaction mixture 
has a lower viscosity than that of bulk polymerization. Lower viscosity facilitates a more 
uniform heat distribution throughout the polymerization mixture and reduces the molecular 
weight polydispersity of the obtained polymers (19). Suspension polymerization was decided 
against due to the added complexity introduced by its high dependence on stirring rate.  
 After being vacuum distilled to remove stabilizer, vinyl butyrate was polymerized in 
stirred DMF at 60°C in a water bath for 24 hr under nitrogen. Precipitation of the polymer was 
initially attempted in chilled ether but was unsuccessful. Instead, the reaction mixture was 
poured in chilled distilled water, resulting in a polymer precipitate, which was subsequently 
Table 2: Reaction conditions for the polymerization of vinyl butyrate. 
  
dried under vacuum at room temperature for 24 hr
found to be soluble in DMF, 
insoluble in water. A molecular weight of 7073 as measured by gel permeation chromatography 
(GPC) was considered low, so the concentration of initiator wa
in hopes of raising the molecular weight
concentration range (Table 2).  
poly(vinyl butyrate) samples identified 
temperature peak. Change in solvent to acetone from DMF produced a markedly hi
Figure 9: Synthesis and degradation of poly(VEPA) and poly(VEVA). A: Polymerization of VEPA and VEVA monomer. B: 
Degradation of poly(VEPA) and poly
14 
. The initial poly(vinyl butyrate) sample was 
methanol, acetone, toluene, dichloromethane and THF
s reduced in the following trials
, but no trend was noticeable within the used initiator 
Differential scanning calorimetry (DSC) performed
them as amorphous without a
(VEVA) into poly(vinyl alcohol) and their respective carboxylic acids.
, but 
 
 on several 
 crystallization 
gher 
 
  
molecular weight, so polymerizati
to be the starting point for VEPA and VEVA polymerization.
Polymerization of VEPA and VEVA
Figure 9 describes the polymerization of VEPA and VEVA by the addition of the free 
radical initiator AIBN. Poly(VEPA) and poly(VEVA) take the form of polyvinyl alcohol chains with 
HDAC inhibitors attached to the chains 
enzymatic hydrolysis will attack these esters and result in polyvinyl alcohol
and generally recognized as safe (GRAS)
3 lists the conditions of poly(VEPA) and poly(VEVA) 
Table 3: Poly(VEPA) and poly(VEVA) polymerization and precipitation conditions.
15 
on in acetone under conditions stated in Table 2 was chosen 
  
 
as pendant groups by their esters. Ideally, chemi
 (which is nontoxic 
 by the FDA) and HDAC inhibitor carboxylic acids.
polymerizations conducted
 
cal or 
  Table 
. Conditions 
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matching that of the final poly(vinyl butyrate) polymerization were first attempted. When that 
proved unsuccessful, the amount of initiator was varied in order to rule out that insufficient 
amount of initiator limited the polymerization. Benzene and methanol were substituted for 
acetone in an attempt to reduce chain transfer to solvent. Finally, vinyl acetate was substituted 
for VEPA monomer. Vinyl acetate is commonly produced by free radical solution 
polymerization, so its failure to polymerize under these conditions denoted a severe flaw in the 
procedure.  
A literature search uncovered a study (20) that examined the molecular weight of 
poly(vinyl acetate) when polymerized in methanol solution with varying solvent/monomer 
weight ratios (Figure 10). An inverse relationship between solvent/monomer ratio and 
molecular weight was found. Given that the poly(VEPA) solvent/monomer ratios attempted far 
exceeded that of (20), further polymerizations were instead conducted at a solvent/monomer 
Figure 10: Effect of varied solvent/monomer weight ratio on molecular weight in the solution polymerization of 
poly(vinyl acetate). Figure attributed to (20). 
17 
 
 
ratio of 1. A representative small-scale polymerization procedure involved 100 mg VEPA, 100 
mg methanol and 2 mg AIBN (2% wt) heated under nitrogen in an oil bath at 60°C for 48 hr. As 
polymerization progressed the homogenous reaction mixture formed two distinct layers – a 
layer of viscous white polymer and a layer of solvent above – making it more accurately termed 
a precipitation polymerization. The excess solvent could be pipetted away, and the impure 
polymer was found to be insoluble in methanol, hexanes and water.  
Precipitation of gram-scale polymers was carried out by dissolving the impure polymer 
in 2x volume dichloromethane (DCM) and adding dropwise into 200 mL stirred methanol.  
Polymer flakes formed but the majority of precipitated polymer accumulated on magnetic 
stirrer bar and beaker walls as a sticky white solid. The milky white precipitation solution was 
decanted into 50 mL Falcon tubes and centrifuged down at 4000 rpm for 10 min, then decanted 
Figure 11: Differential Scanning Calorimetry (DSC) data taken from a sample of poly(VEPA). 
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again. The polymer remaining in the centrifuge tube as well as the polymer accumulated in the 
precipitation flask was redissolved in DCM. Polymer was purified by repeating this precipitation 
procedure once more. Polymer solution was concentrated by rotary evaporator and dried 
under vacuum at room temperature for 24 hr.  
Poly(VEPA) and poly(VEVA) polymers were clear, soft, stringy and gel-like at room 
temperature. Thus, it was expected that these polymers were amorphous. DSC data taken from 
a poly(VEPA) sample demonstrated a glass transition temperature (Tg) of -12.5°C and no 
detectable crystallization peak (Figure 11). GPC conducted on a poly(VEPA) sample gave a 
weight-average molecular weight of 25,800 and PDI of 2.43. Also investigated was the 
possibility of synthesizing electrospun films from these polymers. At the experimental scales 
shown in Table 3, a poly(VEPA) or poly(VEVA) solution dried to sufficient viscosity for 
electrospinning was beneath the minimum required volume for a film to be produced. The 
amorphous and sticky nature of the polymer in bulk form made it difficult to work with and 
incurred material losses when transferring it between vessels. Though unoptimized for handling 
characteristics and/or a higher glass transition temperature, the successful polymerization of 
VEPA and VEVA fulfilled the second specific aim stated in Chapter 1.   
Direct esterification of poly(vinyl alcohol) with PBA 
 The reaction of acid chlorides with polyvinyl alcohol (PVA) leads to poly(vinyl esters) 
(21). Hence, instead of polymerizing VEPA and VEVA we have utilized preformed PVA and 
reacted the available hydroxyl groups with corresponding acid chloride. The reaction scheme 
for this approach is given in Figure 12. PBA was reacted with 1.1 eq thionyl chloride and a 
catalytic amount of DMF in THF or chloroform under nitrogen atmosphere. The reactants were 
  
brought to reflux and reacted for 3 hr to form phenylbutyric acid chloride (P
reacted with 2.5 eq of PBACl under nitrogen atmosphere at reflux. 
acetate or 10% acetate. Reaction times of 2 hr
overnight the PBACl solution turned 
remained un-dissolved in PBACl solution including the more reactive 10% acetate variety
PVA. The reaction mixtures were passed through a PTFE disc filter and 
stirred hexanes but no precipitation occurred. 
not found to be a practical means of preparing poly(VEPA) under the conditions examined here. 
It is possible future studies may have more success i
different reaction mixture more 
 
 
Figure 12: Reaction scheme for the d
19 
PVA was of either 1.5% 
 and overnight were attempted. W
from yellow to a dark brownish-black. The majority of PVA 
added d
Esterification of poly(vinyl alcohol) with PBA was 
n utilizing PVA of different purity or a 
capable of solubilizing PVA.  
irect esterification of poly(vinyl alcohol) with PBA
BACl). PVA was 
hen left 
 of 
ropwise in 
. 
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CHAPTER 3: MICROPARTICLE PREPARATION AND CHARACTERIZATION 
Microparticle preparation 
 Microparticles and nanoparticles prepared from bioactive polymers are an established 
means of drug delivery (22). Microparticles can facilitate cell-induced aggregation and may be 
sintered together to form porous scaffolds for use in tissue engineering and regenerative 
medicine applications (23). Poly(VEPA) and poly(VEVA) microparticles were investigated for 
their ease of use as a tool in the evaluation of polymer degradation and for their potential as a 
scaffold material in future studies.  
Microparticles were prepared by an emulsion-solvent evaporation method with a typical 
procedure as follows: 50-100 mg of polymer was dissolved in 2 ml dichloromethane and 
dropped in 6-8 ml of 1% PVA, then emulsified with a homogenizer at 30,000 rpm for 5 minutes 
while chilled in an ice bath. Emulsified solution was poured into 200 ml 0.1% PVA and slowly 
stirred for 1 hour (poly(VEVA)) or 3 hours (poly(VEPA)). Microparticles were isolated by 
centrifugation at 4000 rpm for 10 minutes (poly(VEPA)) or 20,000 rpm for 40 minutes 
(poly(VEVA)), redispersed by sonication and vortexing and washed once with DI water 
(poly(VEPA) only). It was found that when poly(VEVA) particles were prepared under the same 
conditions as poly(VEPA), the poly(VEVA) particles could not be pelleted during centrifugation. 
Particles were then suspended in 10 ml DI water, frozen in a -80°C freezer for 1 hr and 
lyophilized for 48 hr. These lyophilized microparticles took the form of a flat, sticky paste that 
could not be resuspended in solution. When 5% sucrose, a common cryoprotectant (24), was 
added to the pre-freeze suspension, the final lyophilized product took the form of a dry white 
21 
 
 
fluffy powder. The powder form was a desirable product because it facilitated easy 
measurement of microparticles and a stable shelf life when frozen. 
Microparticle characterization 
 Mixed results were obtained when attempting to resuspend sucrose-protected 
lyophilized microparticles. When thoroughly sonicated and vortexed after centrifugation, 
poly(VEPA) particles could be resuspended 4-5 times in water before the pellet seized up. 
Poly(VEVA) particles could be resuspended once in water but proved resistant to further 
centrifugation, even at upwards of 40,000 rpm for 1 hr. Scanning electron microscopy (SEM) 
images (Figure 13) taken of poly(VEPA) and poly(VEVA) microparticles show sections of discrete 
A 
B 
C 
D 
Figure 13: Scanning electron micrograph of poly(VEPA) (A,B) and poly(VEVA) (C,D) microparticle samples. 
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spheres in the 20-40 μm diameter range. Larger masses of agglomerated polymer with sphere-
like projections were also present in samples examined.  Poly(VEPA) and poly(VEVA) 
microparticles prepared did fulfill the third specific aim listed in Chapter 1, but their size was 
not very uniform and significant agglomeration occurred. Greater consistency in microparticle  
morphology would make them a more attractive scaffold material. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
CHAPTER 4: EVALUATION OF POLYMER DEGRADATION
Degradation mechanisms 
 Poly(VEPA) and poly(VEVA) were expected to degrade in two ways. 
hydrolysis, hydrolytic scission of the ester groups
and VEVA from their polyvinyl alcohol chain with the addition of water. 
the scission of ester groups is catalyzed by the addition of 
Polyvinyl alcohol has low cytotoxicity and carries generally recognized as safe (GRAS) status
making it an attractive degradation product.
undergo surface erosion, an assumption was made that they would undergo 
commonly observed bulk erosion
of a sample, results of hydrolysis studies cond
the polymer in bulk. 
Figure 14: Hydrolytic degradation of poly(VEPA).
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 separates the pendant carboxylic acids
In enzymatic
an enzyme such as lipase (25). 
 As these polymers were not tuned to specifically 
 (26). Because bulk erosion is not dependent on surface area 
ucted on polymer particles were representative of 
 
In chemical 
 VEPA 
 hydrolysis, 
 
the more 
  
Evaluation of chemical and enzymatic hydrolysis
Hydrolytic degradation was evaluated by examination of dry weight loss and isolation of 
degradation products. In the dry weight loss experiment
poly(VEVA) particles were measured into small centrifuge tubes and dispersed in
of four freshly prepared solutions: phosphate buffered saline (PBS) at pH 7.4, citric 
acid/trisodium citrate buffer at pH 3.0
10.8, and lipase from Candida antarctica
amount of lipase applied falls withi
Samples were prepared in triplicate. Samples were placed in a 37
time points of 1, 3 and 5 days. A set of sample
and dried under vacuum at room temperature for
Figure 15: Hydrolytic degradation of poly(VEVA).
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, samples of 3-5mg poly(VEPA) and
, sodium carbonate/sodium bicarbonate buffer at pH 
 (1.16 U/mg) at 0.1 mg/ml in PBS at pH 7.4. 
n the reference range of concentration in human serum (25). 
°C shaker and taken out at 
s at each time point were washed with DI water 
 24 hr, while remaining samples were 
 
 
 1 ml of each 
The 
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centrifuged, decanted and filled with fresh buffer before being returned to incubation. Samples 
were weighed before incubation and after drying to calculate dry % weight loss. Results are 
displayed in Figures 14 and 15. No significant degradation of polymer was detected by measure 
of dry weight loss.  
Isolation of degradation products was investigated by the use of high-performance 
liquid chromatography (HPLC). Because valproic acid could not be measured by the UV detector 
present within HPLC equipment, only hydrolysis of poly(VEPA) was examined. Samples (in 
triplicate) of 10-15mg of poly(VEPA) particles were dispersed in PBS at pH 7.4, citric 
acid/sodium tricitrate buffer at pH 3.0 and sodium carbonate/sodium bicarbonate buffer at pH 
10.8. Samples were incubated in a 37°C shaker for 9 days. At day 1 and every 2 days following 
samples were removed from the shaker, centrifuged, decanted into vials for analysis and 
replaced with fresh buffer. An HPLC concentration curve for PBA was prepared by analyzing 
solutions of PBA in HPLC water. Sample solutions of acidic or basic pH were neutralized for 
compatibility with the HPLC column by dropwise addition of HCl or Na2CO3, respectively. HPLC 
analysis conducted on these samples demonstrated a nearly undetectable quantity of PBA 
present (data not shown). In an attempt to extract more degradation products, a separate 
sample of poly(VEPA) particles dispersed in PBS at pH 7.4 was kept in a block incubator for 15 hr 
at 65°C. Given the experimental value obtained for molecular weight of poly(VEPA), ideal 
release of PBA could be calculated. When analyzed for PBA content (Figure 16), the sample 
contained only 3.7% of the expected quantity for 100% hydrolysis. HPLC and dry weight loss 
results both provide evidence for the claim that no substantial degradation of polymer by 
hydrolysis took place in vitro.  
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MTT assay 
An MTT assay was used to evaluate the cytotoxicity of poly(VEPA) and poly(VEVA) 
microparticles. HeLa cells were seeded in 96 well culture plates and cultured to confluency in 
Dulbecco’s modified eagle’s medium (DMEM) with 10% fetal bovine serum (FBS). Five sample 
groups in triplicate were added to the cell culture plate in doses of 10, 50, 100, 200, 400, and 
800 μg/ml. Sample groups were poly(VEPA) microparticles, poly(VEVA) microparticles, polyvinyl 
alcohol (10% acetate), PBA and VPA. The dose range examined was consistent with an MTT 
assay of VPA (27) and applications of VPA (11) and PBA (5) reported in the literature. After 24 
hours of incubation at 37°C the cells were washed with PBS and MTT assay was conducted 
(Figure 17). 
The results of the MTT assay were inconsistent with expectations. Poly(VEPA) and 
poly(VEVA) microparticles were found to promote cell growth and not inhibit it. The cause was 
found to be residual cryoprotective sucrose from the lyophilization process. A new MTT assay 
for microparticle samples was conducted under the same conditions, but instead of direct 
dispersion into culture medium the microparticles were washed once with water and once with 
ethanol before dispersion. However, as previously mentioned poly(VEVA) particles could not be 
centrifuged successfully in water under any centrifugation conditions attempted (upwards of 
40,000 rpm for 1 hour). Instead, an MTT assay was run solely on washed poly(VEPA) particles 
(Figure 18). Poly(VEPA) particles without sucrose were found to cause no significant cytoxicity 
to HeLa cells. To cause no significant cell death among HeLa cells in vitro is a further 
demonstration that poly(VEPA) is not vulnerable to hydrolysis under physiological conditions 
and is thus ineffective as a drug delivery scaffold material. 
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A 
B 
Figure 16: HPLC analysis of hydrolyzed poly(VEPA) microparticles. (A) Calibration solution of 25 μg PBA in HPLC water. (B) 
8.9 mg Poly(VEPA) microparticles incubated for 15 hr at 65°C in PBS. 
  
  
Figure 17: Evaluation of cytotoxicity of sucrose
Figure 18: Evaluation of cytotoxicity of sucrose
28 
-adulterated poly(VEPA) and poly(VEVA) microparticles on HeLa cells by 
MTT assay. 
-free poly(VEPA) microparticles on HeLa cells by MTT assay. 
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CHAPTER 5: CONCLUSION 
 In this study, valproic acid and phenylbutyric acid-based vinyl polymers were 
successfully prepared from iridium complex-catalyzed vinyl ester monomers by free radical 
polymerization. Polymerization by means of reaction between phenylbutyric acid chloride or 
valproic acid chloride and polyvinyl alcohol was unsuccessful due to insufficient solubility of 
polyvinyl alcohol in reaction medium. Poly(VEPA) and poly(VEVA) microparticles on the 20-40 
μm diameter scale were successfully prepared from bulk polymer and verified by SEM, but 
poly(VEVA) microparticles proved incapable of withstanding any wash cycles. Ultimately these 
polymers failed to exhibit the necessary properties for their use as a biodegradable scaffold 
material in the generation of iPSCs or as an anti-inflammatory agent. Examination of hydrolysis 
at varied pH and with the inclusion of lipase by dry weight loss and HPLC failed to produce 
evidence of any significant degradation of polymer under a timeframe suitable for iPSC 
generation. An assay that would examine the HDAC inhibition of HeLa cells in the presence of 
poly(VEPA) and poly(VEVA) microparticles was planned for but determined to be unnecessary 
in light of the conclusiveness of other findings. It is proposed that the addition of bulky and/or 
phenyl-containing pendant groups may have contributed to an overly hydrophobic nature of 
polymer and protected the esters from hydrolytic attack. If future studies examine polymers 
derived from these HDAC inhibitors it is advisable to link them to a polymer backbone with a 
bond more susceptible to short-term degradation.  
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 HDAC inhibitors are known to have anti-inflammatory properties. HDAC inhibitors are 
used in combination with Oct4 to generate induced pluripotent stem cells. I hypothesized that 
polyesters based on simple aliphatic HDAC inhibitors like valproic acid (VPA) and phenylbutyric 
acid (PBA) can serve as alternatives to existing polyester biomaterials with improved anti-
inflammatory properties and as scaffolds for generation of iPSCs when used in combination 
with layer-by-layer thin films delivering reprogramming transcription factors. Vinyl ester of 
phenylbutyric acid (VEPA) and vinyl ester of valproic acid (VEVA) were synthesized from their 
carboxylic acid precursors using an iridium complex catalyst at yields as high as 97% and 73%, 
respectively. Amorphous poly(VEPA) and poly(VEVA) polymers were prepared by free radical 
solution polymerization and characterized for molecular weight and glass transition 
temperature. Poly(VEPA) and poly(VEVA) microparticles of 20-40 μm diameter were prepared 
by an emulsion-solvent evaporation method and examined under scanning electron microscopy 
(SEM). Their hydrolytic degradation was studied by dry weight loss and HDAC inhibitor release 
via high performance liquid chromatography (HPLC) in the presence of varied pH and lipase-
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containing buffers. No significant degradation occurred within 5 days, and an MTT assay 
conducted on HeLa cells in the presence of these microparticles confirmed an absence of 
cytotoxicity. Poly(VEPA) and poly(VEVA) microparticles were not found to be a suitable 
biomaterial for hypothesized applications in light of their poor degradation characteristics in 
vitro. 
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